Clinical Trial Update: An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating VX-880 for efficacy, safety, and tolerability in participants with Type 1 diabetes and a kidney transplant is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• VX-880

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Type 1 Diabetes, Kidney Transplant | Phase 3 | Status: RECRUITING